Search

everythinglearnresearchcommunity

for

Search:↓

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

FFA's causes may include environmental triggers and genetic factors.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

New alopecia treatments aim for better results and fewer side effects.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Erlotinib can cause hair loss as a side effect.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

About 20% of Japanese macaques had head alopecia, and stress and environment might cause hair loss.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.